THEMONT-AX Tablets

THEMONT-AX Tablets

THEMONT-AX Tablets contain Levocetirizine 5 mg, Montelukast 10 mg and Ambroxol 75 mg (Sustained Release) in a bilayered film-coated tablet formulation. Available in 10×10 Alu-Alu packing, the product should be used under professional medical guidance.

THEMONT-AX Tablets contain a combination of Levocetirizine Dihydrochloride 5 mg, Montelukast Sodium 10 mg and Ambroxol Hydrochloride 75 mg (Sustained Release). The bilayered film-coated tablet formulation is supplied in 10×10 Alu-Alu packing and is intended for use as directed by a qualified healthcare professional.

Key Highlights

  • Levocetirizine Dihydrochloride 5 mg
  • Montelukast Sodium 10 mg
  • Ambroxol Hydrochloride 75 mg (Sustained Release)
  • Bilayered film-coated tablet formulation
  • 10 × 10 Alu-Alu packing
  • Prescription pharmaceutical formulation
  • Use as directed by a qualified healthcare professional
Business Guide*
close slider
Scroll to Top